Biotechnology
Cancer Prevention
Biopharmaceutical
Sorrento Therapeutics
$2.589876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.08 (3.20%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell SRNE and other stocks, options, ETFs, and crypto commission-free!
About SRNE
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. Read More The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
CEO
Employees
382
Headquarters
San Diego, California
Founded
2006
Market Cap
305.78M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.09M
High Today
$2.58
Low Today
$2.50
Open Price
$2.50
Volume
600.31K
52 Week High
$6.88
52 Week Low
$1.80
Collections
Biotechnology
Cancer Prevention
Biopharmaceutical
Therapy
Research And Development
Health
Pharmaceutical
Manufacturing
SRNE News
Price Paid on Robinhood
47% Lower
Right Now
52 Week Low
$1.80
Average Price Paid
$4.85
52 Week High
$8.25
SRNE Earnings
-$0.73
-$0.43
-$0.12
$0.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.34 per share
Actual
Expected Aug 9, After Hours